Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001641172-25-020765
Filing Date
2025-07-24
Accepted
2025-07-23 21:58:05
Documents
3
Effectiveness Date
2025-07-24

Document Format Files

Seq Description Document Type Size
1 S-8 POS forms-8pos.htm S-8 POS 63526
2 EX-23.3 ex23-3.htm EX-23.3 3691
3 EX-99.3 ex99-3.htm EX-99.3 7906
  Complete submission text file 0001641172-25-020765.txt   76301
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-286612 | Film No.: 251144368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)